We are live on
!
Find out more
Zevra Therapeutics
ZVRA
ZVRA
72 hedge funds and large institutions have $32.6M invested in Zevra Therapeutics in 2022 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 11 increasing their positions, 30 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
8% less call options, than puts
Call options by funds: $5.47M | Put options by funds: $5.93M
4.82% less ownership
Funds ownership: 25.74% → 20.92% (-4.8%)
13% less funds holding
Funds holding: 83 → 72 (-11)
28% less capital invested
Capital invested by funds: $45.4M → $32.6M (-$12.8M)
43% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 23
63% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 30
Holders
72
Holders Change
-11
Holders Change %
-13.25%
% of All Funds
1.21%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
13
Increased
11
Reduced
30
Closed
23
Calls
$5.47M
Puts
$5.93M
Net Calls
-$459K
Net Calls Change
-$527K
Top Buyers
| 1 |
LCM
Laurion Capital Management
New York
|
+$2.65M |
| 2 |
HP
HealthInvest Partners
Stockholm,
Sweden
|
+$1.89M |
| 3 |
E
Ergoteles
New York
|
+$658K |
| 4 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$589K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$314K |
Top Sellers
| 1 |
BlackRock
New York
|
-$6.38M |
| 2 |
State Street
Boston,
Massachusetts
|
-$2.05M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.02M |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$929K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$661K |
